Literature DB >> 20425483

Cryptogenic cirrhosis: what are we missing?

Stephen Caldwell1.   

Abstract

Cryptogenic cirrhosis remains a common clinical condition although recent advances have allowed for a better understanding of underlying conditions and associations. The evolving terminology applied to this condition has resulted in some confusion and persistent variation among pathologists and clinicians. Typical patients are middle aged with only minor liver enzyme abnormalities. Presentations range from incidentally discovered cirrhosis to complications of advanced portal hypertension and hepatocellular cancer. Clinicopathologic analysis of these patients indicates that the leading causes include previously unrecognized nonalcoholic steatohepatitis, silent autoimmune hepatitis, non-B, non-C viral hepatitis, and occult past ethanol exposure. In this article, we review these associations as well as a proposed classification system for cryptogenic cirrhosis and other lesser known genetic and syndromic associations that warrant consideration when evaluating these individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425483     DOI: 10.1007/s11894-009-0082-7

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  74 in total

1.  Liver transplantation for cryptogenic cirrhosis.

Authors:  M R Charlton; M Kondo; S K Roberts; J L Steers; R A Krom; R H Wiesner
Journal:  Liver Transpl Surg       Date:  1997-07

2.  Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.

Authors:  Arie Regev; Constanza Guaqueta; Enrique G Molina; Andrew Conrad; Vishnu Mishra; Mark L Brantly; Maria Torres; Maria De Medina; Andreas G Tzakis; Eugene R Schiff
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-07       Impact factor: 2.839

3.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

5.  Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.

Authors:  R Nosadini; A Avogaro; F Mollo; C Marescotti; A Tiengo; E Duner; C Merkel; A Gatta; R Zuin; S de Kreutzenberg
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

6.  Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis.

Authors:  J Koskinas; J G Kenna; G L Bird; G J Alexander; R Williams
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

7.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

8.  Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis.

Authors:  Scott J Cotler; Kiran Kanji; Ali Keshavarzian; Donald M Jensen; Shriram Jakate
Journal:  J Clin Gastroenterol       Date:  2004-10       Impact factor: 3.062

9.  Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

Authors:  S K Roberts; T M Therneau; A J Czaja
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.

Authors:  S Heringlake; A Schütte; P Flemming; W Schmiegel; M P Manns; H L Tillmann
Journal:  Z Gastroenterol       Date:  2009-05-05       Impact factor: 2.000

View more
  10 in total

1.  Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis.

Authors:  Deepak Amarapurkar; Anjali Amarapurkar
Journal:  J Clin Exp Hepatol       Date:  2015-10-23

Review 2.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

3.  An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Romina Lomonaco; Janet Chen; Kenneth Cusi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

4.  Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients.

Authors:  Alexandra Sima; Romulus Timar; Adrian Vlad; Bogdan Timar; Mihaela Rosu; Isabel Dan; Roxana Sirli; Alina Popescu; Ioan Sporea
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

5.  Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.

Authors:  Ashish Goel; Banumathi Ramakrishna; Jayaprakash Muliyil; Kadiyala Madhu; K G Sajith; Uday Zachariah; Jeyamani Ramachandran; Shyamkumar N Keshava; R Selvakumar; George M Chandy; Elwyn Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

6.  Age and ethnicity in cirrhosis.

Authors:  Krishna C Sajja; Desh P Mohan; Don C Rockey
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

7.  NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS.

Authors:  A Sima; I Sporea; R Timar; M Vlad; A Braha; A Popescu; S Nistorescu; R Mare; R Sirli; A Albai; O Albai; L Diaconu; T Sorescu; S Popescu; L Sima
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

8.  Unexplained findings of kayser-fleischer-like rings in a patient with cryptogenic cirrhosis.

Authors:  Mahreema Jawairia; Miral Subhani; Ghulam Siddiqui; Apsara Prasad; Ghulamullah Shahzad; Kaleem Rizvon; Paul Mustacchia
Journal:  Case Rep Gastrointest Med       Date:  2012-03-15

9.  Progressive Familial Intrahepatic Cholestasis: A Rare Cause of Cirrhosis in Young Adult Patients.

Authors:  Gavin R Sun; Michele Burns
Journal:  Case Rep Med       Date:  2015-06-02

10.  Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.

Authors:  Pegah Golabi; Haley Bush; Maria Stepanova; Cameron T Locklear; Ira M Jacobson; Alita Mishra; Gregory Trimble; Madeline Erario; Chapy Venkatesan; Issah Younossi; Zachary Goodman; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.